/
/
/

Medicamen Biotech Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-12%12%22%
--4%-13%49%
--15%-27%-31%
9%7%4%4%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
MEDICAMEQ-BE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,778.6₹424202 Cr38.688.2958.23₹11479 Cr
9,885.5₹264141 Cr90.334.04128.41₹2568 Cr
4,631.9₹174402 Cr82.1114.04106.21₹2163 Cr
2,256.8₹126811 Cr94.648.1733.94₹889 Cr
1,236₹123685 Cr27.419.4262.53₹5040 Cr
1,354.8₹111868 Cr39.9511.0859.2₹4196 Cr
1,384.1₹111650 Cr38.5410.8652.6₹3879 Cr
2,474.6₹102196 Cr45.5717.2376.26₹1913 Cr
1,670.2₹96951 Cr26.1117.9596.84₹3505 Cr
2,009.6₹91301 Cr16.5130.95154.35₹5333 Cr
257.25₹372 Cr34.321.5612.82₹10 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019
₹48 Cr₹61 Cr₹47 Cr₹47 Cr₹43 Cr₹30 Cr₹45 Cr₹45 Cr₹43 Cr₹47 Cr₹47 Cr₹44 Cr₹42 Cr₹39 Cr₹36 Cr₹34 Cr₹33 Cr₹23 Cr₹33 Cr₹33 Cr₹28 Cr₹21 Cr₹33 Cr₹31 Cr₹28 Cr₹24 Cr₹35 Cr₹36 Cr₹31 Cr₹24 Cr
₹86 L₹2 Cr₹54 L₹37 L₹47 L₹5 Cr₹14 L₹29 L₹59 L₹57 L₹83 L₹55 L₹38 L₹35 L₹63 L₹53 L₹96 L₹34 L₹83 L₹48 L₹8 L₹54 L₹10,000₹13 L₹8 L₹1 Cr₹45 L₹35 L₹4 L₹7 L
₹49 Cr₹62 Cr₹47 Cr₹48 Cr₹44 Cr₹35 Cr₹45 Cr₹45 Cr₹44 Cr₹48 Cr₹47 Cr₹44 Cr₹42 Cr₹39 Cr₹36 Cr₹34 Cr₹34 Cr₹23 Cr₹33 Cr₹33 Cr₹28 Cr₹22 Cr₹33 Cr₹31 Cr₹28 Cr₹25 Cr₹36 Cr₹36 Cr₹31 Cr₹24 Cr
₹45 Cr₹57 Cr₹44 Cr₹44 Cr₹40 Cr₹32 Cr₹41 Cr₹42 Cr₹41 Cr₹43 Cr₹43 Cr₹41 Cr₹37 Cr₹34 Cr₹31 Cr₹29 Cr₹29 Cr₹19 Cr₹28 Cr₹28 Cr₹23 Cr₹17 Cr₹28 Cr₹26 Cr₹24 Cr₹21 Cr₹31 Cr₹30 Cr₹27 Cr₹20 Cr
₹5 Cr₹7 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹7 Cr₹6 Cr₹4 Cr₹6 Cr₹6 Cr₹5 Cr₹7 Cr₹7 Cr₹7 Cr₹6 Cr₹7 Cr₹5 Cr₹7 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹6 Cr₹4 Cr₹4 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr
₹83 L₹38 L₹97 L₹99 L₹1 Cr₹65 L₹76 L₹1 Cr₹71 L₹2 Cr₹65 L₹91 L₹96 L₹86 L₹68 L₹62 L₹77 L₹56 L₹49 L₹30 L₹4 L₹36 L₹9 L₹38 L₹24 L₹0₹19 L₹21 L₹16 L₹20 L
₹3 Cr₹5 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹3 Cr₹3 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr
₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹91 L₹80 L₹2 Cr₹2 Cr₹1 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
————————
₹14 Cr₹13 Cr₹13 Cr₹13 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr
₹9 Cr₹0₹0₹3 Cr₹0₹0₹0₹0
₹251 Cr₹199 Cr₹194 Cr₹178 Cr₹134 Cr₹121 Cr₹109 Cr₹75 Cr
₹251 Cr₹199 Cr₹194 Cr₹178 Cr₹134 Cr₹121 Cr₹109 Cr₹75 Cr
₹273 Cr₹212 Cr₹207 Cr₹193 Cr₹146 Cr₹133 Cr₹121 Cr₹87 Cr
₹3 Cr₹1 Cr₹0₹0₹0₹0₹0₹0
₹3 Cr₹4 Cr₹1 Cr₹87 L₹5 Cr₹6 Cr₹2 Cr₹2 L
₹3 Cr₹0₹0₹0₹0₹0₹0₹0
-₹3 Cr-₹3 Cr-₹3 Cr-₹2 Cr-₹50 L₹28 L₹16 L₹41 L
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹98 L
₹5 Cr₹3 Cr₹50 L₹65 L₹6 Cr₹8 Cr₹4 Cr₹1 Cr
————————
₹40 Cr₹43 Cr₹39 Cr₹48 Cr₹43 Cr₹32 Cr₹37 Cr₹31 Cr
₹2 Cr₹1 Cr₹11 Cr₹7 Cr₹5 Cr₹5 Cr₹6 Cr₹78 L
₹42 Cr₹30 Cr₹30 Cr₹23 Cr₹19 Cr₹11 Cr₹8 Cr₹12 Cr
₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr
₹88 Cr₹78 Cr₹85 Cr₹83 Cr₹73 Cr₹53 Cr₹56 Cr₹49 Cr
₹369 Cr₹294 Cr₹292 Cr₹277 Cr₹225 Cr₹194 Cr₹181 Cr₹137 Cr
₹49 Cr₹34 Cr₹31 Cr₹26 Cr₹26 Cr₹19 Cr₹11 Cr₹12 Cr
————————
₹144 Cr₹139 Cr₹137 Cr₹130 Cr₹124 Cr₹116 Cr₹58 Cr₹47 Cr
₹59 Cr₹52 Cr₹45 Cr₹38 Cr₹32 Cr₹26 Cr₹24 Cr₹22 Cr
₹85 Cr₹87 Cr₹92 Cr₹93 Cr₹92 Cr₹90 Cr₹34 Cr₹24 Cr
₹0₹0₹0₹0₹0₹0₹40 Cr₹15 Cr
₹5 Cr₹1 Cr₹1 Cr₹1 Cr₹87 L₹78 L₹63 L₹58 L
₹49 Cr₹35 Cr₹33 Cr₹12 Cr₹1 Cr₹90 L₹29 L₹29 L
₹138 Cr₹123 Cr₹126 Cr₹106 Cr₹94 Cr₹91 Cr₹75 Cr₹40 Cr
————————
₹70 Cr₹62 Cr₹59 Cr₹45 Cr₹27 Cr₹5 Cr₹17 Cr₹15 Cr
₹82 Cr₹69 Cr₹55 Cr₹65 Cr₹63 Cr₹53 Cr₹50 Cr₹43 Cr
₹31 Cr₹4 Cr₹15 Cr₹21 Cr₹4 Cr₹4 Cr₹3 Cr₹9 Cr
₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹20 Cr₹23 Cr₹22 Cr₹15 Cr
₹39 Cr₹27 Cr₹28 Cr₹30 Cr₹9 Cr₹11 Cr₹13 Cr₹14 Cr
₹224 Cr₹165 Cr₹160 Cr₹163 Cr₹123 Cr₹96 Cr₹104 Cr₹96 Cr
₹136 Cr₹86 Cr₹75 Cr₹81 Cr₹50 Cr₹43 Cr₹48 Cr₹48 Cr
₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹8 Cr₹7 Cr₹2 Cr₹42 L
₹369 Cr₹294 Cr₹292 Cr₹277 Cr₹225 Cr₹194 Cr₹181 Cr₹137 Cr
₹190₹161₹158₹145₹114₹103₹98₹74
₹190₹161₹158₹145₹114₹103₹98₹74

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
₹12 Cr₹10 Cr₹13 Cr₹17 Cr₹18 Cr₹16 Cr₹18 Cr₹17 Cr
₹9 Cr₹10 Cr₹11 Cr₹9 Cr₹7 Cr₹3 Cr₹3 Cr₹2 Cr
-₹52 Cr-₹26 Cr-₹28 Cr-₹29 Cr-₹18 Cr-₹3 Cr-₹4 Cr-₹11 Cr
-₹31 Cr-₹7 Cr-₹4 Cr-₹3 Cr₹7 Cr₹17 Cr₹17 Cr₹8 Cr
-₹33 Cr-₹8 Cr-₹7 Cr-₹6 Cr₹4 Cr₹13 Cr₹13 Cr₹4 Cr
-₹3 Cr-₹1 Cr-₹6 Cr-₹6 Cr-₹8 Cr-₹18 Cr-₹37 Cr-₹15 Cr
₹64 Cr-₹1 Cr₹6 Cr₹29 Cr₹4 Cr₹6 Cr₹19 Cr-₹4 Cr
₹28 Cr-₹11 Cr-₹6 Cr₹17 Cr-₹7 L₹80 L-₹5 Cr-₹14 Cr
₹4 Cr₹15 Cr₹21 Cr₹4 Cr₹4 Cr₹3 Cr₹9 Cr₹23 Cr
₹31 Cr₹4 Cr₹15 Cr₹21 Cr₹4 Cr₹4 Cr₹3 Cr₹9 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)263.60
Volume (₹)33,709.00
High (₹)265.00
Upper Circuit273.10
Low (₹)247.10
Lower Circuit247.10
Prev Close260.10
52W High (₹)447.65
Price265.00
52W Low (₹)212.40

Share Market Cap & Key Ratios Overview

M.Cap (₹)371.61 Cr
Div. Yield (%)0.38
PE Ratio34.32
Debt to Equity0.19
Price to Book1.18
Book Value190.02
EPS (TTM)7.70
Face Value10.00
ROE (%)4.23

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
MEDICAMEQ-BENSE
LTP
1W Low
1W High
Market cap (₹)
1769.9+8.9 (0.51%)
1722
1855
4,24,202Cr
10064+400 (4.14%)
9621.50
10064
2,64,141Cr
4650+70 (1.53%)
4532
4675
1,74,402Cr
2323+79 (3.52%)
2206.10
2441.90
1,26,811Cr
1240.6+56.2 (4.75%)
1182
1254.20
1,23,685Cr
1368.3+23.3 (1.73%)
1336.70
1368.30
1,11,868Cr
1396.9+38.9 (2.86%)
1357
1396.90
1,11,650Cr
2475+5.7 (0.23%)
2457.90
2528
1,02,196Cr
1694.5+34.6 (2.08%)
1647.20
1697.40
96,951Cr
2015.9+26 (1.31%)
1974
2033.80
91,301Cr
265-1.95 (-0.73%)
247.10
274
372Cr

Medicamen Biotech Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹5.19Cr; with other income of ₹86.2Lakh, profit before interest and tax came to ₹3.4Cr. Interest expense was ₹82.9Lakh; PBT before exceptional items stood at ₹2.57Cr. Cost mix (full year): raw materials ₹71.9Cr; employee cost ₹30.87Cr; depreciation ₹1.79Cr; other expenses ₹43.57Cr. Basis: consolidated annual results.

Medicamen Biotech Ltd Quaterly Results Key Takeaways

Medicamen Biotech Ltd reported ₹47.9Cr total income from operations in Jun 2026, softer than ₹60.65Cr in Mar 2026 but higher than ₹43.05Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹5.19Cr; with other income of ₹86.2Lakh, profit before interest and tax came to ₹3.4Cr. Interest expense was ₹82.9Lakh, taking profit before tax to ₹2.57Cr. After tax of ₹72.6Lakh, profit after tax stood at ₹1.84Cr (vs ₹4.45Cr in Mar 2026 and ₹1.6Cr in Jun 2025).